Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Pancreatic Cancer
PANCREATIC CANCER ADVISOR
FEATURED CONTENT
-
-
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials. -
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future. -
Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records. -
Vitamin D and Pancreatic Cancer: is There a Link?
Vitamin D is a biomarker of interest in the pancreatic cancer setting.
PANCREATIC CANCER NEWS
Eligibility Criteria for Pancreatic Cancer Trials Exclude More Black Patients Than White Patients
Napabucasin Provides No Added Benefit in Metastatic Pancreatic Cancer
Sex Inequalities Persist in Cancer Clinical Trials
Rucaparib Maintenance Deemed Safe, Effective for Advanced Pancreatic Cancer
Minority Patients Remain Underrepresented in Clinical Trials of Pancreatic Cancer
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Pancreatic Cancer
Loading... 
Loading...